z-logo
open-access-imgOpen Access
The role of HOX genes in normal hematopoiesis and acute leukemia
Author(s) -
Raed Alharbi,
Ruth Pettengell,
Hardev Pandha,
Richard Morgan
Publication year - 2012
Publication title -
leukemia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.539
H-Index - 192
eISSN - 1476-5551
pISSN - 0887-6924
DOI - 10.1038/leu.2012.356
Subject(s) - hox gene , homeobox , haematopoiesis , biology , myeloid leukemia , gene , fusion gene , leukemia , transcription factor , myeloid , cancer research , genetics , stem cell , lymphopoiesis , homeotic gene , immunology
The homeobox (HOX) genes are a highly conserved family of homeodomain-containing transcription factors that specify cell identity in early development and, subsequently, in a number of adult processes including hematopoiesis. The dysregulation of HOX genes is associated with a number of malignancies including acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL), where they have been shown to support the immortalization of leukemic cells both as chimeric partners in fusion genes and when overexpressed in their wild-type form. This review covers our current understanding of the role of HOX genes in normal hematopoiesis, AML and ALL, with particular emphasis on the similarities and differences of HOX function in these contexts, their hematopoietic downstream gene targets and implications for therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom